31 May 2020>: Clinical Research
Comparative Study of Drug-eluting Beads versus Conventional Transarterial Chemoembolization for Treating Peculiar Anatomical Sites of Gastric Cancer Liver Metastasis
Hao Xu 1ABCDEFG* , Xuli Min 1BCDE , Yongjun Ren 1BCDG , Lin Yang 1DEF , Fang Liu 2CDDOI: 10.12659/MSM.922988
Med Sci Monit 2020; 26:e922988
Table 3 Comparison of liver function indexes.
Index | Pre | After 1 week | After 1 month | Fgroup (P) | Ftime (P) | Finteractive (P) |
---|---|---|---|---|---|---|
ALT (U/L) | ||||||
DEB-TACE group | 35.71±16.34 | 58.43±15.76 | 34.24 ± 12.34 | 1.978 (0.342) | 10.754 ( | 3.3.2 (0.165) |
c-TACE group | 36.78±20.32 | 60.43±20.56 | 32.83±15.47 | |||
AST (U/L) | ||||||
DEB-TACE group | 40.52±16.41 | 46.72 ± 12.61 | 41.00 ± 32.18 | 0.131 (0.719) | 12.710 ( | 0.307 (0.636) |
c-TACE group | 33.57±13.21 | 36.48 ± 7.09 | 46.13 ± 34.41 | |||
TBIL (μmol/L) | ||||||
DEB-TACE group | 18.65±11.45 | 21.58±13.25 | 17.43±13.42 | 0.124 (0.864) | 0.768 (0.564) | 0.352 (0.657) |
c-TACE group | 19.21±13.21 | 23.42 ± 15.78 | 21.53±12.21 | |||
PT (S) | ||||||
DEB-TACE group | 11.23±0.64 | 11.58±0.86 | 12.87±0.93 | 0.238 (0.732) | 0.261 (0.874) | 0.236 (0.789) |
c-TACE group | 10.87±0.74 | 14.24±1.21 | 12.53±0.93 | |||
Data represents the mean±standard deviation. Repeated measured ANOVA was used to compare the laboratory indexes before and after treatment |